8
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Critical Incidents: Failure in Prevention

&
Pages 797-820 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

KarolL. Kumpfer. (2002) Prevention of alcohol and drug abuse: What works?. Substance Abuse 23:sup1, pages 23-45.
Read now
Georgia B. Aktan. (1995) Organizational Frameworks of a Substance Use Prevention Program. International Journal of the Addictions 30:2, pages 185-201.
Read now

Articles from other publishers (6)

Trina M. Norden-Krichmar, Ian R. Gizer, Ondrej Libiger, Kirk C. Wilhelmsen, Cindy L. Ehlers & Nicholas J. Schork. (2014) Correlation analysis of genetic admixture and social identification with body mass index in a Native American Community. American Journal of Human Biology 26:3, pages 347-360.
Crossref
Cindy L. Ehlers, Ian R. Gizer, David A. Gilder, Jarrod M. Ellingson & Rachel Yehuda. (2013) Measuring historical trauma in an American Indian community sample: Contributions of substance dependence, affective disorder, conduct disorder and PTSD. Drug and Alcohol Dependence 133:1, pages 180-187.
Crossref
Jay Johnson. (2000) Cost-effectiveness of mental health services for persons with a dual diagnosis A literature review and the CCMHCP. Journal of Substance Abuse Treatment 18:2, pages 119-127.
Crossref
Colin Mangham. (1999) Tobacco Reduction: A Continued Health Promotion ChallengeRéduire le tabagisme: encore et toujours un défi pour la promotion de la santé. Canadian Journal of Public Health 90:2, pages 77-79.
Crossref
Erin Morrissey, Abraham Wandersman, Diana Seybolt, Maury Nation, Cindy Crusto & Katie Davino. (1997) Toward a framework for bridging the gap between science and practice in prevention: A focus on evaluator and practitioner perspectives. Evaluation and Program Planning 20:3, pages 367-377.
Crossref
Louis A. Pagliaro & Ann Marie Pagliaro. (2013) The Phenomenon of Abusable Psychotropic Use Among North American Youth. The Journal of Clinical Pharmacology 33:8, pages 676-690.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.